Situation
A pharmaceutical distributor supplying 340 pharmacies and 18 hospitals across six governorates needed ISO 9001 certification to retain a European manufacturer contract. The company had no quality department, no documented procedures, and entirely manual warehouse management with no product traceability. A product recall 14 months prior had involved 3,200 temperature-sensitive injectable units stored outside cold chain requirements, costing USD 210,000 and producing a Ministry of Health formal warning.
Complication
The European manufacturer had made cold chain traceability a specific certification requirement beyond standard ISO 9001. The Ministry of Health warning meant the certification audit would be conducted under heightened scrutiny. Internally, three warehouse supervisors associated the word 'quality system' with the investigation that followed the recall and refused to participate in initial process mapping sessions.
The Critical Decision — What Almontather Rassoul Saw and Did Differently
I made the decision to restructure the process mapping sessions around the recall incident directly rather than avoiding it. I brought the three resistant supervisors into a facilitated session where we mapped exactly what had gone wrong in the recall sequence — not to assign blame, but to design a system that would prevent a repeat. That approach converted resistance into ownership. The supervisors who had refused to participate became the primary authors of the cold chain monitoring protocol.
Methodology — Why This Approach and Not Another
I built the entire QMS narrative around cold chain as the core process rather than treating it as one of many processes. The reasoning was commercial: the European manufacturer's requirement was the certification trigger, and the audit scope needed to directly address that requirement. A generic ISO 9001 system treating cold chain as an appendix would not have satisfied the contract condition.
Resolution — Delivered by Almontather Rassoul / MRC Firm Ltd.
A quality management system with cold chain risk as its core process narrative: 16 documented processes including a cold chain monitoring protocol with defined alert thresholds and response procedures, co-authored by warehouse supervisors. Training for 34 staff. Two internal audits before the external stage. The audit scope was coordinated directly with the certification body to include a specific cold chain assessment. The European manufacturer received the audit report and certificate before the contract renewal deadline. Zero revisions requested.
What Was Not Fully Resolved — and Why
The Ministry of Health warning remained on the company's regulatory record beyond the engagement. ISO certification demonstrates current compliance capability, not historical compliance. This was disclosed clearly at engagement outset. The company's regulatory standing with the Ministry improved, but the warning was not expunged.
“The three supervisors who initially refused to participate in the quality process ended up writing the cold chain protocol. That transformation happened because Rassoul was willing to address the recall directly rather than work around it. Every other advisor had told us to move forward without revisiting it.”
— Operations Director, Baghdad Pharma Distributor
Consultant: Almontather Rassoul, PhD · MRC Firm Ltd. · montather-rassoul.com · linkedin.com/in/montatherrassoul